“The potential for diagnostic information to drive decision-making has never been greater or more important. As healthcare becomes more personalized and treatment more targeted we need to be innovative about how we think about what test to do when, how to interpret data for clinicians and patients, and how to pay for this information.”
— Caroline Popper, MD, MPH, Founder and President of Popper and Company
